ESG

Investment firm Malar Group backs wellness startup Attaboy Labs, betting on clinical science over marketing hype in the booming supplement industry.

Microban’s new EcoFresh odor control gets the USDA Certified Biobased label, signaling a major shift toward sustainable, high-performance textiles.

Taiwanese foundry UMC posts a 108% profit surge, driven by strong 22nm chip demand, a key Intel partnership, and a positive outlook despite global risks.

The hardware maker's strategic shift to high-value parts for AI and EVs results in a stunning 177% profit surge, signaling a new era of global growth.

DJI's new report reveals agricultural drones cut 51Mt in carbon emissions and saved 410Mt of water, marking a major shift in global food production.

Berlin-based Tacalyx is advancing its lead drug, TCX-201, to the clinic, targeting a novel class of antigens once thought impossible to drug.

At SynBioBeta 2026, Ansa Biotechnologies unveils a bold on-time guarantee, challenging rivals and promising to accelerate research with its advanced DNA tech.

A new provider launches personalized ABA therapy in Colorado homes, addressing service gaps for children with autism with plans for a future clinic.

A new stem cell therapy promises a one-time cure for hemophilia A, and the FDA is clearing the path. Could lifelong, costly infusions become a memory?

The RTD giant is launching its first limited-edition flavor, Transfusion, using a streetwear-style 'drop' to tap into the booming golf lifestyle market.

Student entrepreneurs from 15 countries converge in San Diego to pitch world-changing ideas, from pineapple-fiber hair ties to crypto for Gen Z.

Beloved SF institution Bi-Rite Market announces a new Richmond District store, promising to revitalize a historic site and deepen its community-first mission.

Oral care leader quip and skincare giant Glowbar partner, signaling a major shift toward simplified, habit-driven wellness. What does this mean for you?

Once a hospital disinfectant, hypochlorous acid is now a skincare star. Magic Molecule's massive CVS launch signals a major shift in the beauty industry.

The largest deal in epigenetic testing sees TruDiagnostic's parent buy Dr. David Sinclair's Tally Health, aiming to make personalized longevity mainstream.

With a new industry giant on its board and fresh funding, Phagenesis is set to scale its groundbreaking neuromodulation therapy for swallowing disorders.

A new Georgia development is trading fairways for farm-to-table living, centering an entire community around food. But can this model redefine luxury?

A new partnership aims to expand a proven trenchless technology, promising to fix aging gas pipes faster, cheaper, and with far less disruption.

A novel, FDA-cleared wound therapy is rolling out to military and veteran hospitals, aiming to rewrite the rules of healing for the most complex injuries.

Anika Therapeutics posts strong Q1 results with a 13% revenue jump, but analyst caution lingers over pipeline risks and long-term sustainability.